Beyond the Injection: The Practical Power of an Oral Small Molecule Orforglipron is an investigational, once-daily small molecule (non-peptide) oral glucagon-like peptide-1 (GLP-1) receptor agonist
The market was shrinking, and BCBSLA was concentrated in it
Because they're less costly to distribute and produce, GLP-1 pills do cost less than injectables
66 (Tables 1 and 2) Current GLP-1RAs GLP-1RAs are synthetic protein preparations that have partial or complete amino acid sequence homology with GLP-1 found in the body, are not easily degraded, have longer half-lives and have stronger biological activity
for the 8 mg dose, these figures were 100%, 91%, and 75%
Although 16 of the 30 amino acids in its N-terminus are identical to human GLP-1 (36) amide, exendin-4 is not the lizard homolog of GLP-1